{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:21:49Z","timestamp":1793830909894,"version":"4.6.1"},"reference-count":65,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.ygyno.2020.06.487","type":"journal-article","created":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T17:43:33Z","timestamp":1593711813000},"page":"794-802","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["A guide to establishing a hyperthermic intraperitoneal chemotherapy program in gynecologic oncology"],"prefix":"10.1016","volume":"158","author":[{"given":"Laura M.","family":"Chambers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony B.","family":"Costales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Crean-Tate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Kuznicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molly","family":"Morton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Horowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffany","family":"Jagielo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter G.","family":"Rose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chad","family":"Michener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Debernardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2020.06.487_bb0005","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ygyno.2007.03.019","article-title":"Treatment of ovarian cancer with paclitaxel- or carboplatin-based intraperitoneal hyperthermic chemotherapy during secondary surgery","volume":"106","author":"Bae","year":"2007","journal-title":"Gynecol.Oncol."},{"key":"10.1016\/j.ygyno.2020.06.487_bb0010","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1245\/s10434-014-3599-4","article-title":"Treatment of microscopic disease with hyperthermic intraoperative intraperitoneal chemotherapy after complete cytoreduction improves disease-free survival in patients with stage IIIC\/IV ovarian cancer","volume":"21","author":"Cascales-Campos","year":"2014","journal-title":"Ann.Surg.Oncol."},{"key":"10.1016\/j.ygyno.2020.06.487_bb0015","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1056\/NEJMoa1708618","article-title":"Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer","volume":"378","author":"van Driel","year":"2018","journal-title":"N.Engl.J.Med."},{"key":"10.1016\/j.ygyno.2020.06.487_bb0020","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.ejso.2013.09.030","volume":"39","author":"Bakrin","year":"2013","journal-title":"Eur.J.Surg.Oncol."},{"key":"10.1016\/j.ygyno.2020.06.487_bb0025","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1245\/s10434-016-5686-1","article-title":"Cytoreduction (Peritonectomy Procedures) Combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Advanced Ovarian Cancer: Retrospective Italian Multicenter Observational Study of 511 Cases","volume":"24","author":"Di Giorgio","year":"2017","journal-title":"Ann.Surg.Oncol."},{"key":"10.1016\/j.ygyno.2020.06.487_bb0030","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1001\/jamasurg.2013.3640","article-title":"Surgical outcomes of hyperthermic intraperitoneal chemotherapy: analysis of the american college of surgeons national surgical quality improvement program","volume":"149","author":"Jafari","year":"2014","journal-title":"JAMA Surg."},{"key":"10.1016\/j.ygyno.2020.06.487_bb0035","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1177\/0267659109106815","article-title":"Belmont hyperthermia pump in the conduct of intra-operative heated chemotherapy","volume":"24","author":"Riley","year":"2009","journal-title":"Perfusion."},{"key":"10.1016\/j.ygyno.2020.06.487_bb0040","author":"U.S Food & Drug Administration"},{"key":"10.1016\/j.ygyno.2020.06.487_bb0045","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1002\/1097-0142(196709)20:9<1351::AID-CNCR2820200902>3.0.CO;2-#","article-title":"Selective heat sensitivity of cancer cells. Biochemical and clinical studies","volume":"20","author":"Cavaliere","year":"1967","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2020.06.487_bb0050","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1002\/1097-0142(197706)39:6<2637::AID-CNCR2820390650>3.0.CO;2-S","article-title":"Effect of hyperthermia on malignant cells in vivo. A review and a hypothesis","volume":"39","author":"Overgaard","year":"1977","journal-title":"Cancer."},{"key":"10.1016\/j.ygyno.2020.06.487_bb0055","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S1055-3207(03)00029-2","article-title":"Rationale for hyperthermia with intraoperative intraperitoneal chemotherapy agents","volume":"12","author":"Sticca","year":"2003","journal-title":"Surg. Oncol. Clin. N. Am."},{"key":"10.1016\/j.ygyno.2020.06.487_bb0060","doi-asserted-by":"crossref","first-page":"396","DOI":"10.3109\/02656736.2015.1007399","article-title":"Intra-abdominal temperature distribution during consolidation hyperthermic intraperitoneal chemotherapy with carboplatin in the treatment of advanced stage ovarian carcinoma","volume":"31","author":"Rettenmaier","year":"2015","journal-title":"Int.J.Hyperthermia."},{"key":"10.1016\/j.ygyno.2020.06.487_bb0065","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/0022-4804(91)90014-D","article-title":"Effects of intraperitoneal chemotherapy on anastomotic healing in the rat","volume":"50","author":"Fumagalli","year":"1991","journal-title":"J.Surg.Res."},{"key":"10.1016\/j.ygyno.2020.06.487_bb0070","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4251\/wjgo.v2.i2.68","article-title":"Hyperthermic intraperitoneal chemotherapy: Rationale and technique","volume":"2","author":"Gonz\u00c3\u00a1lez-Moreno","year":"2010","journal-title":"World J.Gastrointest.Oncol."},{"key":"10.1016\/j.ygyno.2020.06.487_bb0075","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1002\/jso.23776","article-title":"Higher flow rates improve heating during hyperthermic intraperitoneal chemoperfusion","volume":"110","author":"Furman","year":"2014","journal-title":"J.Surg.Oncol."},{"key":"10.1016\/j.ygyno.2020.06.487_bb0080","first-page":"18","article-title":"Then and now: cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC), a historical perspective","volume":"7","author":"Neuwirth","year":"2016","journal-title":"J.Gastrointest.Oncol."},{"key":"10.1016\/j.ygyno.2020.06.487_bb0085","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/00001813-199607000-00016","article-title":"Effects of intra-abdominal pressure on pharmacokinetics and tissue distribution of doxorubicin after intraperitoneal administration","volume":"7","author":"Jacquet","year":"1996","journal-title":"Anti-Cancer Drugs"},{"key":"10.1016\/j.ygyno.2020.06.487_bb0090","first-page":"431","article-title":"Research on the best chemohyperthermia technique of treatment of peritoneal carcinomatosis after complete resection","volume":"1","author":"Elias","year":"2000","journal-title":"Int.J.Surg.Investig."},{"key":"10.1016\/j.ygyno.2020.06.487_bb0095","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/jso.21061","article-title":"Hyperthermic intraperitoneal chemotherapy: nomenclature and modalities of perfusion","volume":"98","author":"Glehen","year":"2008","journal-title":"J.Surg.Oncol."},{"key":"10.1016\/j.ygyno.2020.06.487_bb0100","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2019.5420","article-title":"Occupational reproductive hazards for female surgeons in the operating room: A review","author":"Anderson","year":"2020","journal-title":"JAMA Surg."},{"key":"10.1016\/j.ygyno.2020.06.487_bb0105","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.ejso.2016.09.008","article-title":"Best practice for perioperative management of patients with cytoreductive surgery and HIPEC","volume":"43","author":"Raspe","year":"2017","journal-title":"Eur.J.Surg.Oncol."},{"key":"10.1016\/j.ygyno.2020.06.487_bb0110","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1515\/pp-2017-0010","article-title":"Pharmacological principles of intraperitoneal and bidirectional chemotherapy","volume":"2","author":"de Bree","year":"2017","journal-title":"Pleura Peritoneum."},{"key":"10.1016\/j.ygyno.2020.06.487_bb0115","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.soc.2012.07.013","article-title":"Pharmacology of perioperative intraperitoneal and intravenous chemotherapy in patients with peritoneal surface malignancy","volume":"21","author":"Van der Speeten","year":"2012","journal-title":"Surg.Oncol.Clin.N.Am."},{"key":"10.1016\/j.ygyno.2020.06.487_bb0120","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.soc.2018.02.009","article-title":"Learning Curve, Training Program, and Monitorization of Surgical Performance of Peritoneal Surface Malignancies Centers","volume":"27","author":"Kusamura","year":"2018","journal-title":"Surg.Oncol.Clin.N.Am."},{"key":"10.1016\/j.ygyno.2020.06.487_bb0125","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1245\/s10434-017-6284-6","article-title":"Implications of Hyperthermic Intraperitoneal chemotherapy perfusion-related hyperglycemia","volume":"25","author":"Stewart","year":"2018","journal-title":"Ann.Surg.Oncol."},{"key":"10.1016\/j.ygyno.2020.06.487_bb0130","doi-asserted-by":"crossref","first-page":"972","DOI":"10.4103\/ija.IJA_765_19","article-title":"Society of Onco-Anaesthesia and Perioperative Care consensus guidelines for perioperative management of patients for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC)","volume":"63","author":"Solanki","year":"2019","journal-title":"Indian J.Anaesth."},{"key":"10.1016\/j.ygyno.2020.06.487_bb0135","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0959-8049(97)00370-5","article-title":"Intraperitoneal cisplatin with regional hyperthermia in advanced ovarian cancer: pharmacokinetics and cisplatin-DNA adduct formation in patients and ovarian cancer cell lines","volume":"34","author":"van de Vaart","year":"1998","journal-title":"Eur.J.Cancer."},{"key":"10.1016\/j.ygyno.2020.06.487_bb0140","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S1055-3207(03)00051-6","article-title":"Pharmacokinetics of heated intraoperative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis","volume":"12","author":"Elias","year":"2003","journal-title":"Surg.Oncol.Clin.N.Am."},{"key":"10.1016\/j.ygyno.2020.06.487_bb0145","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.ejso.2019.10.032","article-title":"Toxicity profile of chemotherapy agents used in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancies","volume":"46","author":"Somashekhar","year":"2020","journal-title":"Eur.J.Surg.Oncol."},{"key":"10.1016\/j.ygyno.2020.06.487_bb0150","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1245\/s10434-016-5143-1","article-title":"Cytoreductive Surgery Combined with Hyperthermic Intraperitoneal Chemotherapy with Oxaliplatin Increases the Risk of Postoperative Hemorrhagic Complications: Analysis of Predictive Factors","volume":"23","author":"Charrier","year":"2016","journal-title":"Ann.Surg.Oncol."},{"key":"10.1016\/j.ygyno.2020.06.487_bb0155","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ygyno.2005.11.013","article-title":"Intraperitoneal catheter outcomes in a phase III trial of intravenous versus intraperitoneal chemotherapy in optimal stage III ovarian and primary peritoneal cancer: a gynecologic oncology group study","volume":"100","author":"Walker","year":"2006","journal-title":"Gynecol.Oncol."},{"key":"10.1016\/j.ygyno.2020.06.487_bb0160","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1200\/JCO.2003.04.187","article-title":"Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer","volume":"21","author":"Verwaal","year":"2003","journal-title":"J.Clin.Oncol."},{"key":"10.1016\/j.ygyno.2020.06.487_bb0165","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S1055-3207(03)00031-0","article-title":"Pharmacokinetics of intraperitoneal mitomycin C","volume":"12","author":"van Ruth","year":"2003","journal-title":"Surg.Oncol.Clin.N.Am."},{"key":"10.1016\/j.ygyno.2020.06.487_bb0170","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/jso.23228","article-title":"Treatment-related morbidity and toxicity of CRS and oxaliplatin-based HIPEC compared to a mitomycin and doxorubicin-based HIPEC protocol in patients with peritoneal carcinomatosis: a matched-pair analysis","volume":"107","author":"Glockzin","year":"2013","journal-title":"J.Surg.Oncol."},{"key":"10.1016\/j.ygyno.2020.06.487_bb0175","doi-asserted-by":"crossref","first-page":"4244","DOI":"10.1245\/s10434-012-2496-y","article-title":"Perioperative management of patients undergoing cytoreductive surgery combined with heated intraperitoneal chemotherapy for peritoneal surface malignancy: a multi-institutional experience","volume":"19","author":"Bell","year":"2012","journal-title":"Ann.Surg.Oncol."},{"key":"10.1016\/j.ygyno.2020.06.487_bb0180","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1007\/s11605-015-2743-1","article-title":"A randomized trial of goal directed vs. standard fluid therapy in cytoreductive surgery with hyperthermic intraperitoneal chemotherapy","volume":"19","author":"Colantonio","year":"2015","journal-title":"J.Gastrointest.Surg."},{"key":"10.1016\/j.ygyno.2020.06.487_bb0185","doi-asserted-by":"crossref","first-page":"3652","DOI":"10.1245\/s10434-019-07644-w","article-title":"Standard operating procedures for anesthesia Management in Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Improve Patient Outcomes: a patient cohort analysis","volume":"26","author":"Fichmann","year":"2019","journal-title":"Ann.Surg.Oncol."},{"key":"10.1016\/j.ygyno.2020.06.487_bb0190","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/01.sla.0000094387.50865.23","article-title":"Danish Study Group on Perioperative Fluid Therapy, Effects of intravenous fluid restriction on postoperative complications: comparison of two perioperative fluid regimens: a randomized assessor-blinded multicenter trial","volume":"238","author":"Brandstrup","year":"2003","journal-title":"Ann.Surg."},{"key":"10.1016\/j.ygyno.2020.06.487_bb0195","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/00000542-200507000-00008","article-title":"Effect of intraoperative fluid management on outcome after intraabdominal surgery","volume":"103","author":"Nisanevich","year":"2005","journal-title":"Anesthesiology."},{"key":"10.1016\/j.ygyno.2020.06.487_bb0200","doi-asserted-by":"crossref","first-page":"235","DOI":"10.21037\/jgo.2018.12.11","article-title":"The effect of intraoperative fluid administration on outcomes of patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy","volume":"10","author":"Shamavonian","year":"2019","journal-title":"J.Gastrointest.Oncol."},{"key":"10.1016\/j.ygyno.2020.06.487_bb0205","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1245\/s10434-017-5869-4","article-title":"Base excess as a predictor of complications in Cytoreductive surgery with Hyperthermic Intraperitoneal chemotherapy","volume":"24","author":"Eng","year":"2017","journal-title":"Ann.Surg.Oncol."},{"key":"10.1016\/j.ygyno.2020.06.487_bb0210","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000439387","article-title":"Acute kidney injury in the surgical patient: recognition and attribution","volume":"131","author":"Bihorac","year":"2015","journal-title":"Nephron."},{"key":"10.1016\/j.ygyno.2020.06.487_bb0215","first-page":"188","article-title":"Anaesthetic management and perioperative outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: a retrospective analysis, Indian J","volume":"62","author":"Balakrishnan","year":"2018","journal-title":"Anaesth."},{"key":"10.1016\/j.ygyno.2020.06.487_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.suronc.2016.03.007","article-title":"Morbidity and mortality outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients aged 75 years and over: Spanish group of peritoneal cancer surgery (GECOP) multicenter study","volume":"25","author":"Cascales-Campos","year":"2016","journal-title":"Surg.Oncol."},{"key":"10.1016\/j.ygyno.2020.06.487_bb0225","doi-asserted-by":"crossref","DOI":"10.1186\/1477-7819-12-136","article-title":"Anaesthesia in patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: retrospective analysis of a single centre three-year experience","volume":"12","author":"Kajdi","year":"2014","journal-title":"World J.Surg.Oncol."},{"key":"10.1016\/j.ygyno.2020.06.487_bb0230","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1007\/s11605-017-3444-8","article-title":"Allogenic blood transfusion is an independent predictor of poorer Peri-operative outcomes and reduced Long-term survival after Cytoreductive surgery and Hyperthermic Intraperitoneal chemotherapy: a review of 936 cases","volume":"21","author":"Saxena","year":"2017","journal-title":"J.Gastrointest.Surg."},{"key":"10.1016\/j.ygyno.2020.06.487_bb0235","series-title":"Cleveland Clinic Illustrated Tips and Tricks in Colon and Rectal Surgery. Philadelphia: Lippincott Williams & Wilkins","first-page":"255","volume":"239","author":"Steele","year":"2021"},{"key":"10.1016\/j.ygyno.2020.06.487_bb0240","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.ygyno.2019.03.241","article-title":"Risk factors for anastomotic leakage after colorectal resection in ovarian cancer surgery: A multi-centre study","volume":"153","author":"Lago","year":"2019","journal-title":"Gynecol.Oncol."},{"issue":"7","key":"10.1016\/j.ygyno.2020.06.487_bb0245","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1007\/BF02054444","article-title":"Anastomotic leak after double-stapled low colorectal resection","volume":"39","author":"Averbach","year":"1996","journal-title":"Dis. Colon Rectum"},{"key":"10.1016\/j.ygyno.2020.06.487_bb0250","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1245\/s10434-019-07964-x","article-title":"Predictors of Anastomotic Failure After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Does Technique Matter?","volume":"27","author":"Wiseman","year":"2020","journal-title":"Ann.Surg.Oncol."},{"key":"10.1016\/j.ygyno.2020.06.487_bb0255","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s00384-006-0246-y","article-title":"Hyperthermic intraperitoneal chemoperfusion (HIPEC) decrease wound strength of colonic anastomosis in a rat model","volume":"22","author":"Pelz","year":"2007","journal-title":"Int.J.Colorectal Dis."},{"key":"10.1016\/j.ygyno.2020.06.487_bb0260","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1007\/s12094-019-02065-3","article-title":"The use of cisplatin plus doxorubicin or paclitaxel in hyperthermic intraperitoneal chemotherapy (HIPEC) for stage IIIC or IV epithelial ovarian cancer: a comparative study","volume":"21","author":"Manzanedo","year":"2019","journal-title":"Clin.Transl.Oncol."},{"key":"10.1016\/j.ygyno.2020.06.487_bb0270","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s12094-018-1948-7","article-title":"Effect of Paclitaxel-based Hyperthermic Intraperitoneal Chemotherapy (HIPEC) on colonic anastomosis in a rat model","volume":"21","author":"L\u00c33pez-L\u00c33pez","year":"2019","journal-title":"Clin.Transl.Oncol."},{"key":"10.1016\/j.ygyno.2020.06.487_bb0275","doi-asserted-by":"crossref","first-page":"307","DOI":"10.5301\/tj.5000610","article-title":"The effects of hyperthermic intraperitoneal chemoperfusion on colonic anastomosis: an experimental study in a rat model","volume":"103","author":"Aghayeva","year":"2017","journal-title":"Tumori."},{"key":"10.1016\/j.ygyno.2020.06.487_bb0280","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1177\/000313481808400618","article-title":"The impact of Ostomy creation after Cytoreduction and Hyperthermic Intraperitoneal chemotherapy in a newly established peritoneal malignancy program","volume":"84","author":"Stiles","year":"2018","journal-title":"Am.Surg."},{"key":"10.1016\/j.ygyno.2020.06.487_bb0285","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1046\/j.1365-2168.1998.00615.x","article-title":"Risk factors for anastomotic leakage after resection of rectal cancer","volume":"85","author":"Rullier","year":"1998","journal-title":"Br.J.Surg."},{"key":"10.1016\/j.ygyno.2020.06.487_bb0290","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1245\/s10434-015-4961-x","article-title":"Avoiding diverting ileostomy in patients requiring complete pelvic Peritonectomy","volume":"23","author":"Sugarbaker","year":"2016","journal-title":"Ann.Surg.Oncol."},{"key":"10.1016\/j.ygyno.2020.06.487_bb0295","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ygyno.2013.04.002","article-title":"Multiple large bowel resections: potential risk factor for anastomotic leak","volume":"130","author":"Kalogera","year":"2013","journal-title":"Gynecol.Oncol."},{"key":"10.1016\/j.ygyno.2020.06.487_bb0300","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ygyno.2016.05.035","article-title":"Diverting ileostomy during primary debulking surgery for ovarian cancer: associated factors and postoperative outcomes","volume":"142","author":"Tseng","year":"2016","journal-title":"Gynecol.Oncol."},{"key":"10.1016\/j.ygyno.2020.06.487_bb0305","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/jso.25189","article-title":"Safety of rectum anastomosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"118","author":"von Breitenbuch","year":"2018","journal-title":"J.Surg.Oncol."},{"key":"10.1016\/j.ygyno.2020.06.487_bb0310","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1245\/s10434-016-5147-x","article-title":"Splenectomy increases postoperative complications following Cytoreductive surgery and Hyperthermic Intraperitoneal chemotherapy","volume":"23","author":"Dagbert","year":"2016","journal-title":"Ann.Surg.Oncol."},{"key":"10.1016\/j.ygyno.2020.06.487_bb0315","doi-asserted-by":"crossref","first-page":"737","DOI":"10.21037\/jgo.2017.07.09","article-title":"Splenectomy is an independent risk factor for poorer perioperative outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: an analysis of 936 procedures","volume":"8","author":"Saxena","year":"2017","journal-title":"J.Gastrointest.Oncol."},{"key":"10.1016\/j.ygyno.2020.06.487_bb0320","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.gynor.2014.05.001","article-title":"Hyperthermic intra-thoracic chemotherapy (HITeC) for the management of recurrent ovarian cancer involving the pleural cavity","volume":"9","author":"Singh","year":"2014","journal-title":"Gynecol.Oncol.Case Rep."},{"key":"10.1016\/j.ygyno.2020.06.487_bb0330","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1245\/s10434-015-4963-8","article-title":"Routine admission to intensive care unit after Cytoreductive surgery and heated Intraperitoneal chemotherapy: not always a requirement","volume":"23","author":"Mogal","year":"2016","journal-title":"Ann.Surg.Oncol."},{"key":"10.1016\/j.ygyno.2020.06.487_bb0335","first-page":"307317","article-title":"Intensive care unit admission after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Is it necessary?","volume":"2014","author":"L\u00c33pez-Basave","year":"2014","journal-title":"J.Oncol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825820323027?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825820323027?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:51:23Z","timestamp":1758772283000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825820323027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":65,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S0090825820323027"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2020.06.487","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A guide to establishing a hyperthermic intraperitoneal chemotherapy program in gynecologic oncology","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2020.06.487","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}